Martine A Rothblatt Insider Trades & Stock Holdings

Chairperson & CEO · United Therapeutics Corporation · Latest filing Oct 15, 2026

Martine A Rothblatt, Chairperson & CEO at United Therapeutics Corporation has 1 Form 4 trade on file since Oct 15, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($5.19M), net -$5.19M. Latest filing: disposed of 9.50K shares of $UTHR on Oct 15, 2026 at $546.65.

Trades on file

1

Open-market bought

$0

Open-market sold

$5.19M

Net open-market

-$5.19M

Shares held ($UTHR)

324.44K

Latest filing

Oct 15, 2026

Shares held by Martine A Rothblatt

• $UTHR324.44K sh

Shares owned after the most recent Form 4 for each company.

All insider trades by Martine A Rothblatt

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 15, 2026	$UTHR	Sell (Open-market sale) 10b5-1	9.50K	$546.65	$5.19M	324.44K	-2.84%				Chairperson & CEO	SEC	Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Martine A Rothblatt traded

• $UTHR

Frequently asked questions

Has Martine A Rothblatt been buying or selling stock?

Martine A Rothblatt has 0 open-market purchases and 1 open-market sale on file, net -$5.19M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Martine A Rothblatt's latest insider trade?

disposed of 9.50K shares of $UTHR on Oct 15, 2026 at $546.65.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.